Cardiovascular

Latest Boston Sci Deal Shakes up Mitral Repair Market

The Marlborough, MA-based company strengthens its structural heart portfolio and gains a deeper foothold in a market where Medtronic, Abbott Laboratories, and Edwards Lifesciences have already made significant acquisitions.

Paragonix Gets FDA Nod for Pediatric Heart Transport Device

The Braintree, MA-based firm’s Paragonix SherpaPak Cardiac Transport System also has clearance for the adult patient population.

Abiomed’s New Collaboration Could Cause Shockwaves in Industry

The Danvers, MA-based company is poised to invest $15 million in Shockwave Medical and work on a training and education program with the intravascular lithotripsy specialist.

WhiteSwell Develops a Different Way to Treat Heart Failure

The Galway, Ireland-based company has raised $30 million to help develop its approach to drain the excess fluid found in acute decompensated heart failure patients.

Large Companies Eye Collaboration as Entry into AI

The partnership between Edwards Lifesciences and Bay Labs continues the trend of larger medtech firms teaming up with companies in the artificial intelligence space to enhance existing devices.

CardioFocus Finishes up Enrollment for HeartLight X3 Trial

The Marlborough, MA-based company said it could pick up a CE mark for the endoscopic ablation system sometime in mid-2019.

Is 2019 Going to Be a Standout Year for TAVR?

JenaValve has received a nod from FDA to expand enrollment in an IDE of its TAVR system. The measure comes at a time when the TAVR landscape is expected to shift.

New Corindus Technology Successfully Used in Robotic-Assisted Coronary Intervention

The developer of precision vascular robotics announced its CorPath GRX System was successfully used in robotic-assisted coronary interventions.

How a New Blood Volume Analyzer Could Save Lives From Acute Heart Failure

Daxor’s new technology designed to measure blood volume has the potential to reduce patient readmission rates and improve outcomes for patients suffering from acute heart failure.

BioCardia Developing Comprehensive Approach to Treat Heart Failure

Enrollment for the CardiAmp Cell Therapy System could be completed by the end of 3Q19.

AliveCor Heats up Mobile ECG Market with New Data

The release of the ST LEUIS trial data comes on the heels of Apple receiving FDA clearance for an ECG app for the Apple Watch.

Cardiva Medical Has Strong Showing at AHA

The Santa Clara, CA-based company filed its PMA submission with FDA earlier this year and hopes to be able to launch the technology in the first half of 2019.

One of the Top 25 Medtech M&A Targets Has Strong Quarter

Abiomed has topped Wall Street consensus this quarter and has raised its outlook for the year.

Abbott's HeartMate 3 Pump Can Now be Offered as a Destination Therapy

FDA has approved the use of Abbott's Heartmate 3 device for advanced heart failure patients who are not eligible for a transplant. These patients will live with their device for the rest of their life.

What's Next for Bioresorbable Scaffolds?

Abbott Laboratories presented some disappointing data for its bioresorbable stent program at TCT, but it was a different story for Reva Medical's scaffold.

Qmed Search Form